Noncontiguous finished genome sequence and description of Necropsobacter massiliensis sp. nov.

New Microbes New Infect

Faculté de médecine, URMITE, UM63, CNRS 7278, IRD 198, Inserm U1095, Aix-Marseille Université, Marseille, France ; Campus International UCAD-IRD, Senegal.

Published: November 2015


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Strain FF6(T) was isolated from the cervical abscess of a 4-year-old Senegalese boy, in Dakar, Senegal. MALDI-TOF MS did not provide any identification. This strain exhibited a 95.17% 16S rRNA sequence identity with Necropsobacter rosorum. Using a polyphasic study including phenotypic and genomic analyses, strain FF6(T) was an aero-anaerobic Gram-negative cocobacillus, oxidase positive, and exhibited a genome of 2,493,927 bp (1 chromosome but no plasmid) with a G+C content of 46.2% that coded 2,309 protein-coding and 53 RNA genes. On the basis of these data, we propose the creation of Necropsobacter massiliensis sp. nov.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625094PMC
http://dx.doi.org/10.1016/j.nmni.2015.09.007DOI Listing

Publication Analysis

Top Keywords

necropsobacter massiliensis
8
massiliensis nov
8
strain ff6t
8
noncontiguous finished
4
finished genome
4
genome sequence
4
sequence description
4
description necropsobacter
4
nov strain
4
ff6t isolated
4

Similar Publications

Background: Left ventricular diastolic dysfunction (LVDD) is an important precursor of heart failure (HF), but little is known about its relationship with gut dysbiosis and microbial-related metabolites. By leveraging the multi-omics data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a study with population at high burden of LVDD, we aimed to characterize gut microbiota associated with LVDD and identify metabolite signatures of gut dysbiosis and incident LVDD.

Results: We included up to 1996 Hispanic/Latino adults (mean age: 59.

View Article and Find Full Text PDF

MALDI-TOF Mass Spectrometry: A Powerful Tool for Clinical Microbiology at Hôpital Principal de Dakar, Senegal (West Africa).

PLoS One

July 2016

Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, UM63, CNRS7278, IRD198, InsermU1095, Institut Hospitalo-Universitaire Méditerranée-Infection, Aix-Marseille Université, Marseille, France and Dakar, Senegal.

Our team in Europe has developed the routine clinical laboratory identification of microorganisms by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). To evaluate the utility of MALDI-TOF MS in tropical Africa in collaboration with local teams, we installed an apparatus in the Hôpital Principal de Dakar (Senegal), performed routine identification of isolates, and confirmed or completed their identification in France. In the case of discordance or a lack of identification, molecular biology was performed.

View Article and Find Full Text PDF

Noncontiguous finished genome sequence and description of Necropsobacter massiliensis sp. nov.

New Microbes New Infect

November 2015

Faculté de médecine, URMITE, UM63, CNRS 7278, IRD 198, Inserm U1095, Aix-Marseille Université, Marseille, France ; Campus International UCAD-IRD, Senegal.

Strain FF6(T) was isolated from the cervical abscess of a 4-year-old Senegalese boy, in Dakar, Senegal. MALDI-TOF MS did not provide any identification. This strain exhibited a 95.

View Article and Find Full Text PDF